| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate |
1999-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_839fcfb5f8f30bd45c53fbc15ff1a852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104323988d6242b525fa48420ff29c82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca399646322c5ca10091f575f04f0df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_692fe7f3ac200c4de19f9525a1b95366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f769d27b190354d4d4e7d7fc6a3249fb |
| publicationDate |
2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SK-16762000-A3 |
| titleOfInvention |
CD23 ANTIBODIES, PHARMACEUTICAL COMPOSITIONS, DNA SEQUENCES CODING CHAIN ANTIBODIES AND ANTIBODIES USED |
| abstract |
The invention relates to antibodies which bind to the CD23 (FC epsilon RII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FC epsilon RII) type II molecule characterised by an affinity constant equal to or greater than 1x10<9> Ka Mo1<-1>, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders. |
| priorityDate |
1998-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |